New facility for poultry vaccine technology
Intervet/Schering-Plough Animal Health, the global leader in animal health products, announces the opening of its new SPHEREON® vaccine manufacturing facility in Boxmeer.
The facility was opened by Gerda Verburg, Dutch minister of Agriculture, Nature and Food Quality as part of her visit to the Intervet/Schering-Plough Animal Health headquarters in Boxmeer. The new facility, featuring in-house developed manufacturing technology, adds to what is already the largest vaccine R&D and production site in the Dutch pharmaceutical industry.
The innovative SPHEREON® technology freeze-dries live poultry vaccines to small, highly soluble particles (spheres) instead of the traditional vaccine cake in a glass bottle. SPHEREON® vaccines are packaged in light-weight aluminium cups in convenient dose sizes. Dissolving the particles is fast and convenient for administration of the vaccine via water, spray or eye-drop. The ground-breaking concept has been patented by Intervet/Schering-Plough Animal Health and improves both the manufacturing as well as the application of vaccines.
The major advantages of the SPHEREON® vaccine technology are the easy and quick dissolution, hygienic application, availability of high-dosage presentations and large batch sizes. These advantages all contribute to enhanced convenience and reduced risk of inadvertent vaccine exposure.
Related link:
Intervet/Schering-Plough Animal Health
Join 31,000+ subscribers
Subscribe to our newsletter to stay updated about all the need-to-know content in the poultry sector, three times a week.
